Description
The global Endometriosis market estimated at US$1.93 Billion in the year 2021 is now projected to grow at a CAGR of 4.1% and reach US$2.45 Billion by 2027.
The research report provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market. The report provides market estimates and forecast for geographic markets such as the North America (United States, Canada, Mexico and Rest of North America), South America (Brazil, Argentina Chile Colombia Peru Venezuela Ecuador and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Belgium, Finland, Norway, Switzerland, Denmark, Czech Republic, Portugal and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Philippines, Malaysia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel, Oman, Bahrain, Saudi Arabia, Qatar, Egypt and Rest of Middle East) & Africa.
Key players profiled in the report include Abbott Laboratories; AbbVie Inc.; Astellas Pharma Inc.; AstraZeneca Plc; Bayer AG; Debiopharm Group; ElexoPharm; EndoCeutics; Evotec AG; Kissei Pharmaceutical Co. Ltd.; Meditrina Pharmaceuticals Inc.; Myovant Sciences; Neurocrine Biosciences Inc.; ObsEva SA; Pfizer Inc.; Repros Therapeutics Inc.; Takeda Pharmaceutical Company Limited; ValiRx plc among others.
Research Methodology
Table of Contents
- Executive Summary
- Research Methodology
- Primary Research
- Secondary Research
- Market Analytics
- Revenue Forecasting
- Market Overview
- Market Definition
- Scope of the Study
- Research Objectives
- Assumptions & Limitations
- Market Structure
- Market Dynamics
- Introduction
- Microeconomic Factor Analysis
- Market Evolution
- Technology Roadmap
- Demand-Supply Dynamics
- Growth Drivers
- Restraints
- Opportunities
- Challenges
- Sustainable Strategies
- Market Trend Analysis (Product Analysis, Technology Analysis, Application Analysis)
- Industry Analysis
- Profitability analysis
- Supply Chain & Value Chain Analysis
- Porter’s Five Forces Analysis
- Bargaining power of Suppliers
- Bargaining Power of Buyers
- Threat of substitutes
- Threat of new entrants
- Degree of Competition
- PEST Analysis
- Upstream and downstream profitability analysis and opportunities
- COVID-19 impact analysis
- Endometriosis market
- Healthcare & Wellness industry
- Medical Devices industry
- Pharmaceuticals industry
Global Endometriosis Market Scope (Market size and projections, 2021-2027)
- Disease overview
- Disease
- Severity of disease
- Market analysis by type
- Reproductive area endometriosis
- Uterosacral/presacral nerve endometriosis
- Cul-de-sac endometriosis
- Gastrointestinal endometriosis
- Others
- Endometriosis diagnostics & treatments market analysis
- Endometriosis diagnostics
- Medical imaging
- Biopsy
- Clinical & physical examination
- Endometriosis treatments
- Non-steroidal anti-inflammatory (NSAID’s)
- Hormonal therapy
- Non-hormonal therapy
- Surgery and devices
- Others
- Endometriosis diagnostics
- Market analysis by end-use segment
- Hospitals
- Specialty clinics
- Gynecological centers
- Laboratories
- Others
- Emerging trends and technologies
- Endometriosis & endometrial cancer treatments
- Endometrial cancer immunotherapies
- Clinical prognosis
- Noninvasive diagnostics
- Genetic and biomolecular diagnostic tests
- Nanoparticle technology
- Heating magnetic nanoparticles
- Others
- Market analysis by region
- North America
- US
- Canada
- Mexico
- Others
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Venezuela
- Ecuador
- Others
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
- Sweden
- Netherlands
- Poland
- Austria
- Belgium
- Finland
- Norway
- Switzerland
- Denmark
- Czech Republic
- Portugal
- Others
- Asia-Pacific
- China
- Japan
- South Korea
- Taiwan
- India
- Australia
- Indonesia
- Philippines
- Malaysia
- Others
- Middle East
- Iran
- Turkey
- Kuwait
- UAE
- Israel
- Oman
- Bahrain
- Saudi Arabia
- Qatar
- Egypt
- Others
- Africa
- Algeria
- Libya
- South Africa
- Sudan
- Zimbabwe
- Others
- North America
- Competitive Landscape
- Introduction
- Market share analysis by key market players (North America, South America, Europe, APAC, Africa)
- Market Strategy
- Mergers and Acquisitions
- New Product Launches
- Asset Transactions
- Financial Announcements
- Company Profile (key market players)
- Company profile 1
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 2
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 3
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 4
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 5
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 6
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 7
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 8
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 9
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 10
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Other Companies
- Company profile 1
-
-
- 100+
-
